ventricular tachycardia and ventricular fibrillation occurred at plasma concentrations which were not significantly different from those associated with severe side-effects , suggesting that when mexiletine is used to control these major dysrhythmias the incidence of important side effects will be high .
C0025887
mexiletine
C0003811
dysrhythmias